Inluriyo 00002-1717
Generic: Imlunestrant
Product NDC
00002-1717- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- September 25, 2025
- Listing Expires
- December 31, 2027
- Application
- NDA218881
Need to source Inluriyo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Imlunestrant | 200 mg/1 |
Drug Class
Estrogen Receptor Antagonist [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Estrogen Receptor Antagonist [EPC]
Packaging Options(3)
28 TABLET, FILM COATED in 1 BOTTLE (0002-1717-28)
56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-56)
56 TABLET, FILM COATED in 1 BOTTLE (0002-1717-61)